MarketCap
Facebook
X
Telegram
Scopus BioPharma Current Ratio | SCPS
Annual Current Ratio Scopus BioPharma
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 0.519 | 0.903 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.903 | 0.519 | 0.711 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CRISPR Therapeutics AG
CRSP
|
6.6 | $ 45.05 | -9.97 % | $ 4.05 B |  Schweiz |
 |
Scholar Rock Holding Corporation
SRRK
|
2.55 | $ 48.48 | -5.96 % | $ 5.56 B |  USA |
 |
Geron Corporation
GERN
|
1.66 | $ 0.96 | -3.71 % | $ 640 M | USA |
 |
Bristol-Myers Squibb Company
BMY
|
1.26 | $ 62.8 | 1.06 % | $ 128 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
6.05 | - | -3.76 % | $ 3.47 M | USA |
 |
Kazia Therapeutics Limited
KZIA
|
0.422 | $ 7.4 | -0.13 % | $ 113 M |  Australia |
 |
Celldex Therapeutics
CLDX
|
10.4 | $ 30.68 | -1.81 % | $ 2.04 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.29 | $ 4.0 | -6.76 % | $ 48.8 M |  Israel |
 |
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
2.87 | $ 317.26 | 0.99 % | $ 6.14 B | USA |
 |
Eli Lilly and Company
LLY
|
1.16 | $ 1 432.7 | 1.47 % | $ 1.29 T | USA |
 |
TCR2 Therapeutics
TCRR
|
3.09 | - | - | $ 58.1 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
8.39 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
TFF Pharmaceuticals
TFFP
|
4.89 | - | -60.05 % | $ 125 K | USA |
 |
Mesoblast Limited
MESO
|
4.19 | $ 14.0 | -3.06 % | $ 16.9 B | Australia |
 |
CorMedix
CRMD
|
1.96 | $ 5.37 | -2.1 % | $ 387 K | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.05 | - | -15.15 % | $ 60.3 M |  Britain |
 |
MannKind Corporation
MNKD
|
0.939 | $ 4.22 | 0.84 % | $ 1.29 B | USA |
 |
AVEO Pharmaceuticals
AVEO
|
1.77 | - | - | $ 521 M | USA |
 |
MediciNova
MNOV
|
11.4 | $ 1.4 | -4.76 % | $ 68.7 M | USA |
 |
Merck & Co.
MRK
|
1.24 | $ 147.75 | -0.68 % | $ 370 B | USA |
 |
Moderna
MRNA
|
3.35 | $ 250.79 | -6.77 % | $ 97.6 B | USA |
 |
Axcella Health
AXLA
|
1.28 | - | -16.42 % | $ 249 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.53 | - | - | $ 2.02 B | USA |
 |
Intellia Therapeutics
NTLA
|
4.93 | $ 11.18 | -7.72 % | $ 1.21 B | USA |
 |
Novartis AG
NVS
|
1.72 | $ 163.39 | -0.18 % | $ 317 B | Schweiz |
 |
Omeros Corporation
OMER
|
1.87 | $ 17.3 | -1.48 % | $ 1.1 B | USA |
 |
Oramed Pharmaceuticals
ORMP
|
8.93 | $ 3.97 | -0.75 % | $ 164 M | Israel |
 |
Tyme Technologies
TYME
|
11.1 | - | 8.07 % | $ 54 M | USA |
 |
Puma Biotechnology
PBYI
|
2.52 | $ 8.13 | -3.22 % | $ 407 M | USA |
 |
PDS Biotechnology Corporation
PDSB
|
1.44 | $ 1.02 | -5.09 % | $ 47.3 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
2.06 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Pfizer
PFE
|
1.71 | $ 29.34 | 0.36 % | $ 167 B | USA |
 |
Завод ДИОД
DIOD
|
8.75 | - | - | - |  Russia |
 |
PainReform Ltd.
PRFX
|
4.43 | $ 0.78 | -4.24 % | $ 505 K | Israel |
 |
Prothena Corporation plc
PRTA
|
7.05 | $ 8.56 | -2.51 % | $ 461 M | USA |
 |
Arcus Biosciences
RCUS
|
8.49 | $ 18.66 | -1.56 % | $ 2 B | USA |
 |
Orgenesis
ORGS
|
0.0347 | - | -33.86 % | $ 61.2 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
3.16 | $ 14.9 | -1.03 % | $ 12.4 B |  India |
 |
Regeneron Pharmaceuticals
REGN
|
4.36 | $ 916.16 | -0.41 % | $ 95.8 B | USA |
 |
Replimune Group
REPL
|
2 | $ 23.3 | 4.67 % | $ 2.16 B | USA |
 |
Фармсинтез
LIFE
|
0.454 | - | - | - | Russia |
 |
Royalty Pharma plc
RPRX
|
1.98 | $ 69.47 | 1.02 % | $ 29.9 B | USA |
 |
Revolution Medicines
RVMD
|
3.26 | $ 193.0 | -3.57 % | $ 36.7 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
2.28 | $ 113.99 | 0.04 % | $ 7.41 B | USA |
 |
Codiak BioSciences
CDAK
|
1.45 | - | -55.98 % | $ 2.15 M | USA |
 |
Sana Biotechnology
SANA
|
1.63 | $ 2.43 | -1.42 % | $ 615 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
4.21 | $ 61.81 | 0.11 % | $ 172 M | Israel |
 |
Summit Therapeutics
SMMT
|
8.14 | $ 17.78 | -0.34 % | $ 13.3 B | Britain |
 |
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | USA |